Alpha-1-antitrypsin deficiency: Diagnosis, pathophysiology, and management

Current Gastroenterology Reports

Volumn 8, Issue 1, 2006, Pages 14-20

  Teckman, Jeffrey H ^a   Lindblad, Douglas ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; ALANINE AMINOTRANSFERASE; ALPHA 1 ANTITRYPSIN; ASPARTATE AMINOTRANSFERASE; CASPASE;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; AUTOPHAGY; CELLULAR DISTRIBUTION; CLINICAL FEATURE; EMPHYSEMA; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LABORATORY DIAGNOSIS; LIVER CANCER; LIVER CELL; LIVER DISEASE; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PHENOTYPE; POINT MUTATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; RISK ASSESSMENT;

ADULT; ALLELES; ALPHA 1-ANTITRYPSIN DEFICIENCY; CHILD; DISEASE PROGRESSION; EMPHYSEMA; GENOTYPE; HUMANS; LIVER DISEASES; MUTATION;

EID: 33645079400     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-006-0059-8     Document Type: Review

References (52)

1. Perlmutter DH: Alpha-1-antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis 2004, 8:839-859, viii-ix.
2. American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003, 168:818-900.
3. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ 1997, 75:397-415.
4. Sveger T: Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976, 294:1316-1321.
5. Sveger T: alpha 1-antitrypsin deficiency in early childhood. Pediatrics 1978, 62:22-25.
6. Sveger T, Piitulainen E, Arborelius M, Jr: Lung function in adolescents with alpha 1-antitrypsin deficiency. Acta Paediatr 1994, 83:1170-1173.
7. Mowat AP: Alpha 1-antitrypsin deficiency (PiZZ): features of liver involvement in childhood. Acta Paediatr Suppl 1994, 393:13-7.
8. Pittschieler K, Massi C: Alpha 1 antitrypsin deficiency in two population groups in north Italy. Padiatr Padol 1988, 23:307-311.
9. Sveger T, Eriksson S: The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 1995, 22:514-517.
10. Eriksson S: Alpha-1-antitrypsin deficiency: natural course and therapeutic strategies. In Falk Symposium 115: Liver Cirrhosis and Its Development. Edited by Boyer JL, Blum HE, Maier HE, et al. Dordrecht: Kluwer Academic Publishers; 2001:307-315.
11. Eriksson S: Alpha 1-antitrypsin deficiency. J Hepatol 1999, 30(Suppl 1):34-39.
12. An JK, Blomenkamp K, Lindblad D, Teckman JH: Quantitative isolation of alpha1AT mutant Z protein polymers from human and mouse livers and the effect of heat. Hepatology 2005, 41:160-167.
13. Perlmutter DH: Alpha-1-antitrypsin deficiency: biochemistry and clinical manifestations. Ann Med 1996, 28:385-394.
14. Wu Y, Whitman I, Molmenti E, et al.: A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A 1994, 91:9014-9018.
15. Qu D, Teckman JH, Omura S, Perlmutter DH: Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem 1996, 271:22791-22795.
16. Lomas DA, Parfrey H: Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax 2004, 59:529-535.
17. Dafforn TR, Mahadeva R, Elliott PR, et al.: A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem 1999, 274:9548-9555.
18. Lomas DA, Evans DL, Finch JT, Carrell RW: The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992, 357:605-607.
19. Cabral CM, Choudhury P, Liu Y, Sifers RN: Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways. J Biol Chem 2000, 275:25015-25022.
20. Teckman JH, Burrows J, Hidvegi T, et al.: The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 2001, 276: 44865-44872.
21. Teckman JH, Perlmutter DH: Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 2000, 279:G961-G974.
22. Sifers RN: Cell biology. Protein degradation unlocked. Science 2003, 299:1330-1331.
23. Teckman JH, An JK, Blomenkamp K, et al.: Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol 2004, 286: G851-G862.
24. Perlmutter DH: Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum. Methods Mol Biol 2003, 232:39-56.
25. Lomas DA, Evans DL, Stone SR. et al.: Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry 1993, 32:500-508.
26. Lomas DA, Mahadeva R: Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002, 110:1585-1590.
27. Lin L, Schmidt B, Teckman J, Perlmutter DH: A naturally occurring nonpolymerogenic mutant of alpha 1-antitrypsin characterized by prolonged retention in the endoplasmic reticulum. J Biol Chem 2001, 276:33893-3898.
28. Carrell RW, Lomas DA: Alpha1-antitrypsin deficiency - a model for conformational diseases. N Engl J Med 2002, 346:45-53.
29. Cabrita LD, Dai W, Bottomley SP: Different conformational changes within the F-helix occur during serpin folding, polymerization, and proteinase inhibition. Biochemistry 2004, 43:9834-9839.
30. Rudnick DA, Liao Y, An JK, et al.: Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency. Hepatology 2004, 39:1048-1055.
31. Wu Y, Swulius MT, Moremen KW, Sifers RN: Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation. Proc Natl Acad Sci U S A, 2003, 100:8229-8234.
32. Lawless MW, Creene CM, Mulgrew A, et al.: Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. J Immunol, 2004, 172:5722-5726.
33. Teckman JH, An JK, Loethen S, Perlmutter DH: Fasting in alpha1-antitrypsin deficient liver: constitutive [correction of consultative] activation of autophagy. Am J Physiol Gastrointest Liver Physiol 2002, 283:G1156-GG165.
34. Teckman JH, Gilmore R, Perlmutter DH: Role of ubiquitin in proteasomal degradation of mutant alpha(1)-antitrypsin Z in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol 2000, 278:G39-G48.
35. Teckman JH, Perlmutter DH: The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem 1996, 271:13215-13220.
36. Marcus NY, Perlmutter DH: Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha1 antitrypsin Z. J Biol Chem 2000, 275:1987-1992.
37. Lomas DA, Lomas DA, Finch JT, et al.: Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem 1993, 268:15333-15335.
38. Lomas DA, Elliott PR, Sidhar SK, et al.: Alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem 1995, 270:16864-16870.
39. Rodriguez F, Jardi R, Costa X, et al.: Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens. Am J Respir Crit Care Med 2002, 166:814-817.
40. Piitulainen E, Sveger T: Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax 2002, 57:705-708.
41. Sveger T, Thelin T, McNeil TF: Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition. Acta Paediatr 1997, 86:37-40.
42. Teckman JH: Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study. J Pediatr Gastroenterol Nutr 2004, 39:34-37.
43. Duan YY, Wu J, Zhu JL, et al.: Gene therapy for human alphal-antitrypsin deficiency in an animal model using SV40-derived vectors. Gastroenterology 2004, 127:1222-1232.
44. Eigenbrodt ML, McCashland TM, Dy RM, et al.: Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease. Am J Gastroenterol 1997, 92:602-607.
45. Fischer HP, Ortiz-Pallardo ME, Ko Y, et al.: Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ. J Hepatol 2000, 33:883-892.
46. Pittschieler K: Liver disease and heterozygous alpha1-antitrypsin deficiency. Acta Paediatr Scand 1991, 80:323-327.
47. Kaserbacher R, Propst T, Propst A, et al.: Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology 1993, 18:707-708.
48. Propst T, Propst A, Dietze O, et al.: High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 1992, 117:641-645.
49. Hodges JR, Millward-Sadler GH, Barbatis C, Wright R: Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 1981, 304:557-560.
50. Zhou H, Ortiz-Pallardo ME, Ko Y, Fischer HP: Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma? Cancer 2000, 88:2668-2676.
51. Banner BF, Karamitsios N, Smith L, Bonkovsky HL: Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C. Am J Gastroenterol 1998, 93:1541-1545.
52. Mahadeva K, Chang WS, Dafforn TR, et al.: Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest 1999, 103:999-1006.